A. Moeller (Zurich, Switzerland), S. Cunningham (Edinburgh, United Kingdom)
Oxygen kinetics during submaximal cardiopulmonary exercise testing (CPET) in adult patients with cystic fibrosis is related to Schwachman score
E. Armeniakou, G. Perpati, C. Pappas, M. Avdikou, E. Stefanatou, T. Soulele, N. Barouchos, P. Roditis, E. Pouliou, S. Nanas (Athens, Greece)
|   |
Aerobic training and quality of life in cystic fibrosis
A. C. Negrinho Oliveira, T. Almas de Jesus, R. A. Mesquita- Ferrari, J. C. Oliveira, L. V. Franco de Oliveira, L. Malosá Sampaio (Sao Paulo, Cascavél, Brazil)
| |
Quality of life and health utility in patients with cystic fibrosis
J. Bradley, S. Blume, M. Stafford, M. Balp, S. Elborn (Ulster, London, United Kingdom; Bethesda, United States Of America; Basel, Switzerland)
| |
Recurrence of nasal polyposis in cystic fibrosis children and adolescents during five-year follow-up
S. Weber, R. Iyomasa, J. M. Lopes Neto, A. Hepner, G. Ferrari (Botucatu, Brazil)
| |
Efficacy of peripheral deposition of inhaled rhDNase in CF patients during a respiratory tract exacerbation
H. Tiddens, M. Bakker, S. Volpi, E. Salonini, W. Hop, B. Assael (Rotterdam, Netherlands; Verona, Italy)
| |
Pneumothorax in cystic fibrosis. Case-control study
C. J. Carpio Segura, C. Prados Sánchez, R. Girón Moreno, M. T. Martínez, L. Maiz, I. Barrio, C. Martínez, C. Antelo Landeira, J. J. Cabanillas, L. Gómez Carrera, R. Álvarez-Sala Walther (Madrid, Spain)
| |
How to build a new service for cystic fibrosis adult patients? The experience of the CF centre at AO Spedali Civili Brescia
R. Padoan, A. Plebani, G. Tassi, M. A. Berlendis (Brescia, Italy)
| |
Hyperinflation in adult cystic fibrosis (CF) patients: Clinical and functional correlates
X. Dhalluin, T. Perez, B. Wallaert, R. Matran, S. Leroy (Lille, France)
| |
Electrocardiographical characteristics of pulmonary arterial hypertension in children with cystic fibrosis
S. Sciuca, S. Gotnog, O. Turcu, L. Neamtu (Chisinau, Republic Of Moldova)
| |
Cystic fibrosis(CF) severity and polymorphisms(pol) in ACE, GCLC and GST(M1, T1 and P1) genes
F. A. D. L. Marson, J. D. Ribeiro, C. S. Bertuzzo, A. F. Ribeiro (Campinas, Brazil)
| |
TNF gene polymorphisms and asthma development in cystic fibrosis patients
G. Shmarina, A. Pukhalsky, N. Kapranov, V. Alioshkin (Moscow, Russian Federation)
| |
Repeat polymorphisms (pol.) in the NOS-1 gene and its association with the clinical severity of cystic fibrosis (CF)
F. A. D. L. Marson, J. D. Ribeiro, C. S. Bertuzzo, A. F. Ribeiro (Campinas, Brazil)
| |
Effects of the polymorphic variant 5‘FR/G-260C in the multidrug resistance-associate protein-1 gene on severity of cystic fibrosis
A. Leonard, A. Mafficini, M. Ortombina, I. Sermet, P. Lebecque, T. Leal, P. Iansa, G. Reychler, K. Dahan, X. Pepermans, G. Lenoir, C. Sorio, B. M. Assael, P. Melotti (Verona, Italy; Paris, France; Brussels, Belgium)
| |
Alpha-1 antitrypsin (AAT) in cystic fibrosis-associated endoplasmic reticulum (ER) stress
A. Hector, M. Kappler, M. Griese, D. Hartl (Munich, Germany)
| |
Sputum biomarkers of inflammatory in children with cystic fibrosis
T. Bulgakova, E. Surkova, E. Boitsova, L. Jelenina, T. Gembitskaia (St. Petersberg, Russian Federation)
| |
ADRB2R gene polymorphism (pol.) associated with the severity of cystic fibrosis(CF) and the effectiveness of the use of inhaled bronchodilator
F. A. D. L. Marson, J. D. Ribeiro, C. S. Bertuzzo, A. F. Ribeiro (Campinas, Brazil)
| |
Children with CF and the relation with asthma, tuberculosis and aspergilosis
I. Ciuca, L. Pop, Z. Popa, I. Popa (Timisoara, Romania)
| |